School of Medicine to serve as lead site for clinical trial on stuttering
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
By Iqbal Pittalwala |
| Health
More than half of American adults with advanced multiple sclerosis report mistreatment by caregivers
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
By Iqbal Pittalwala |
| Health
Observed COVID-19 variability may have underlying molecular sources
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
By Iqbal Pittalwala |
| Health
Impact of HPV vaccination mandates on social inequalities
Policy has limited impact on vaccine uptake because of individual decision making, study finds
By Iqbal Pittalwala |
| Health
Drug found to correct gene defect that causes immune-driven gut leakiness
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
By Iqbal Pittalwala |
| Health
Developing a COVID-19 vaccine at warp speed
Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
By Iqbal Pittalwala |
| Health